Dr. Robert A. Baffi, Ph.D., serves as an Executive Vice President Technical Operations of Biomarin Pharmaceutical Inc. He joined BioMarin in May 2000 and currently serves as our Executive Vice President of Technical Operations, responsible for overseeing our manufacturing, process development, quality, and analytical chemistry departments. From 2000 to December 2009, Dr. Baffi served as our Senior Vice President of Technical Operations. From 1986 to 2000, Dr. Baffi served in a number of increasingly responsible positions at Genentech, Inc., primarily in the functional area of quality control. Prior to Genentech, Dr. Baffi worked for Cooper BioMedical as a Research Scientist and at Becton Dickinson Research Center as a PostDoctoral Fellow. Dr. Baffi has contributed to more than 20 regulatory submissions for product approval in the United States and Europe and to more than 50 regulatory submissions for investigational new drug testing. He currently serves on the board for the National Institute for Bioprocessing Research Training
Age: 62 EVP Since 2009 MBABaffi received a Ph.D., M. Phil and a B.S. in biochemistry from the City University of New York and an M.B.A. from Regis University.
Robert Baffi Latest Insider Activity
Management EfficiencyThe company has return on total asset (ROA) of (1.89) % which means that it has lost $1.89 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (4.36) % meaning that it created substantial loss on money invested by shareholders.
Entity SummaryBioMarin Pharmaceutical, Inc., a biotechnology company, develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. The company was founded in 1996 and is headquartered in San Rafael, California. BioMarin Pharmaceutical operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 2581 people.BioMarin Pharmaceutical (BMRN) is traded on BATS Exchange in USA. It is located in 770 Lindaro Street and employs 2,581 people. BioMarin Pharmaceutical is listed under Pharmaceutical Products category by Fama And French industry classification.
BioMarin Pharmaceutical Leadership Team
|Elaine Heron, Independent Director|
|Dennis Slamon, Director|
|Henry Fuchs, Executive Vice President and Chief Medical Officer|
|Robert Hombach, Independent Director|
|Brian Mueller, Chief Accounting Officer, Group VP and Controller|
|Bryan Lawlis, Independent Director|
|JeanJacques Bienaime, Chairman of the Board, CEO|
|Jeff Ajer, Executive Vice President Chief Commercial Officer|
|Richard Meier, Independent Director|
|Willard Dere, Director|
|Daniel Spiegelman, CFO, Executive Vice President|
|Kathryn Falberg, Director|
|Eric Davis, Sr. VP, General Counsel and Secretary|
|Pierre Lapalme, Independent Chairman of the Board|
|Robert Baffi, Executive VP of Technical Operations|
|Alan Lewis, Independent Director|
|Richard Ranieri, Senior Vice President - Human Resources and Corporate Affairs|
|David Pyott, Independent Director|
|Michael Grey, Independent Director|
Stock Performance Indicators
Track or share privately all of your investments from the convenience of any device
|All Next||Launch Portfolio Anywhere|
Check also Trending Equities. Please also try CEO Directory module to screen ceos from public companies around the world.